Does RIPRETINIB Cause Hyperkeratosis? 124 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Hyperkeratosis have been filed in association with RIPRETINIB (QINLOCK). This represents 2.8% of all adverse event reports for RIPRETINIB.
124
Reports of Hyperkeratosis with RIPRETINIB
2.8%
of all RIPRETINIB reports
0
Deaths
9
Hospitalizations
How Dangerous Is Hyperkeratosis From RIPRETINIB?
Of the 124 reports, 9 (7.3%) required hospitalization.
Is Hyperkeratosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does RIPRETINIB Cause?
Fatigue (582)
Alopecia (517)
Extra dose administered (357)
Death (356)
Underdose (345)
Nausea (292)
Drug ineffective (291)
Disease progression (290)
Hospitalisation (280)
Neoplasm progression (263)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RITUXIMAB (121)
TOCILIZUMAB (103)
Which RIPRETINIB Alternatives Have Lower Hyperkeratosis Risk?
RIPRETINIB vs RISANKIZUMAB
RIPRETINIB vs RISANKIZUMAB-RZAA
RIPRETINIB vs RISDIPLAM
RIPRETINIB vs RISEDRONATE
RIPRETINIB vs RISEDRONIC ACID